ImmunoPrecise Antibodies Ltd is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services.
The company acquired BioStrand. BioStrand offers a cloud-based solution to perform multi-omics research faster and more accurately, with more effective data analysis.
Labs in Canada, Europe and USA. Small market cap $110.97M.
Price Target $12.00 from August 2022, at current price almost 100% upside - see https://www.ipatherapeutics.com/wp-content/uploads/2022/08/CR_IPA_08012022.pdf.
I think in comparision with overpriced/biggers peers like RXRX, ABCL this is a very interesting company.